Endogenous interferon-alpha level is increased in hepatitis C virus (HCV)-positive pregnant women

J Clin Gastroenterol. 2008 Feb;42(2):204-7. doi: 10.1097/01.mcg.0000247991.81591.2e.

Abstract

Background: Mother-to-child transmission of hepatitis C virus (HCV) has been reported in around 5% of cases, and is much more likely to occur in case of coinfection with HIV. However, other cofactors influencing the vertical transmission are still debated.

Aim: To assess the serum concentration of endogenous interferon (IFN) during pregnancy, and its eventual role on the vertical transmission of HCV.

Methods: Forty-seven HCV-infected pregnant women, and 3 control groups: (1) 75 HCV-negative pregnant women; (2) 29 HCV-positive nonpregnant women; (3) 29 HCV-negative nonpregnant women entered into the study. Endogenous IFN was assayed by enzyme-linked immunosorbent assay. The following parameters were also analyzed: viral load, HIV infection, risk factors for acquiring HCV, parity, gestational age, mode and course of delivery.

Results: Vertical transmission of HCV was observed in 2 cases (4.3%). Plasma levels of IFN were significantly higher in HCV-positive pregnant women compared with either HCV-positive and HCV-negative nonpregnant women. The 2 mothers who transmitted the infection had IFN levels within the same range as the women who did not transmit the infection.

Conclusions: In HCV-positive pregnant women, there is an increased production of endogenous IFN-alpha. Further studies are warranted for clarifying the mechanisms of this cytokine in the prevention of HCV transmission.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Delivery, Obstetric / methods
  • Female
  • HIV Infections / complications
  • Hepatitis C / blood*
  • Hepatitis C / complications
  • Hepatitis C / transmission*
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical*
  • Interferon-alpha / blood*
  • Pregnancy
  • Pregnancy Complications, Infectious / blood*
  • Pregnancy Complications, Infectious / virology*
  • Prospective Studies
  • Risk Factors
  • Viral Load

Substances

  • Interferon-alpha